Venture capital fund · 2 deals
Every published round GV took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Sierra | Series D+ | 4 May 2026 | $950m | Lead | groundy.com, faq.com.tw, theaiworld.org, cmswire.com, aivy.com.au, techbuzz.ai, TechCrunch Venture | |
| Checkmate | Series A | 26 May 2023 | $15m | Lead | Forbes Australia, SmartCompany, Blackbird Ventures portfolio |
Companies GV has backed in a published round, and companies whose existing shares it bought off another holder.
Fund closes reported for GV, as distinct from the investments it has made.
Companies GV has backed that another company then bought. An exit for the holding, not a deal GV did.
Stories naming GV. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Analysis of Sierra's $950 million raise at a $15 billion valuation with Tiger Global and GV at the lead, weighing its revenue multiple, Fortune 50 customer lock-in, and competition from OpenAI and Anthropic's ventures.
Crunchbase's 2026 forecast lists fifteen late-stage companies it deems probable or very likely IPO candidates, profiling each with past raises, valuations and secondary sales; Australia's Canva makes the list.
Weekly roundup of five startup raises: Fleet Space's Series C, Checkmate's Series A, Adventus's new round, Endua's hydrogen funding and Servicely's raise, with investors named.
Also Forbes Australia
Male contraceptive startup Contraline has secured $7.2 million in a GV-led round to progress first-in-human trials of its ADAM hydrogel implant, with initial patients treated in Australia.